Medicina Legal, Psiquiatría y Patología
Departament
University of Cagliari
Cagliari, ItaliaPublicacions en col·laboració amb investigadors/es de University of Cagliari (12)
2024
-
Clinician treatment choices for post-traumatic stress disorder: ambassadors survey of psychiatrists in 39 European countries
European Psychiatry, Vol. 67, Núm. 1
-
Psychopharmacology in children and adolescents: unmet needs and opportunities
The Lancet Psychiatry, Vol. 11, Núm. 2, pp. 143-154
2023
-
Suicidality Treatment Occurring in Paediatrics (STOP) Medication Suicidality Side Effects Scale in young people in two cohorts across Europe
BMJ Open, Vol. 13, Núm. 12
-
The future of child and adolescent clinical psychopharmacology: A systematic review of phase 2, 3, or 4 randomized controlled trials of pharmacologic agents without regulatory approval or for unapproved indications
Neuroscience and Biobehavioral Reviews, Vol. 149
2022
-
Clinical decision-making style preferences of European psychiatrists: Results from the Ambassadors survey in 38 countries
European Psychiatry, Vol. 65, Núm. 1
-
Ethical considerations for precision psychiatry: A roadmap for research and clinical practice
European Neuropsychopharmacology, Vol. 63, pp. 17-34
2020
-
Development and psychometric properties of the “Suicidality: Treatment Occurring in Paediatrics (STOP) Risk and Resilience Factors Scales” in adolescents
European Child and Adolescent Psychiatry, Vol. 29, Núm. 2, pp. 153-165
-
Psychosocial risk factors for suicidality in children and adolescents
European Child and Adolescent Psychiatry, Vol. 29, Núm. 6, pp. 759-776
2019
-
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders
Nature Communications, Vol. 10, Núm. 1
-
Re-thinking treatment targets in child and adolescent psychiatry
European Child and Adolescent Psychiatry
2015
-
Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives
European Neuropsychopharmacology, Vol. 25, Núm. 10, pp. 1513-1531
2009
-
Antipsychotics in children and adolescents: Increasing use, evidence for efficacy and safety concerns
European Neuropsychopharmacology, Vol. 19, Núm. 9, pp. 629-635